<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.dib.2021.107451"><dct:format>application/xml</dct:format><dct:title>The characteristics of mitral regurgitation: Data from patients admitted following acute myocardial infarction</dct:title><dct:creator>Harish Sharma</dct:creator><dct:creator>Ashwin Radhakrishnan</dct:creator><dct:creator>Peter Nightingale</dct:creator><dct:creator>Samuel Brown</dct:creator><dct:creator>John May</dct:creator><dct:creator>Kieran O'Connor</dct:creator><dct:creator>Iqra Shakeel</dct:creator><dct:creator>Nawal Zia</dct:creator><dct:creator>Sagar N. Doshi</dct:creator><dct:creator>Jonathan N. Townend</dct:creator><dct:creator>Saul G. Myerson</dct:creator><dct:creator>Paulus Kirchhof</dct:creator><dct:creator>Peter F. Ludman</dct:creator><dct:creator>M. Adnan Nadir</dct:creator><dct:creator>Richard P. Steeds</dct:creator><dct:subject><rdf:Bag><rdf:li>Mitral regurgitation</rdf:li><rdf:li>Secondary MR</rdf:li><rdf:li>Myocardial infarction</rdf:li><rdf:li>Valvular disease</rdf:li></rdf:Bag></dct:subject><dct:description>Data in Brief 39 (2021). doi:10.1016/j.dib.2021.107451</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>Data in Brief</prism:publicationName><prism:copyright>&#169; 2021 The Authors. Published by Elsevier Inc.</prism:copyright><dct:publisher>Elsevier Inc.</dct:publisher><prism:issn>2352-3409</prism:issn><prism:volume>39</prism:volume><prism:coverDisplayDate>December 2021</prism:coverDisplayDate><prism:doi>10.1016/j.dib.2021.107451</prism:doi><prism:url>http://dx.doi.org/10.1016/j.dib.2021.107451</prism:url><dct:identifier>doi:10.1016/j.dib.2021.107451</dct:identifier><bam:articleNumber>107451</bam:articleNumber><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-10-01T12:54:10Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by/4.0/</oa:userLicense></oa:openAccessInformation><cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY license.</cp:licenseLine></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S300.1</dp:version-number></dp:document-properties><ja:article docsubtype="dat" version="5.6" xml:lang="en"><ja:item-info><ja:jid>DIB</ja:jid><ja:aid>107451</ja:aid><ce:article-number>107451</ce:article-number><ce:pii>S2352-3409(21)00733-2</ce:pii><ce:doi>10.1016/j.dib.2021.107451</ce:doi><ce:document-thread><ce:refers-to-document id="ref0001"><ce:pii>S0002-9149(21)00688-3</ce:pii><ce:doi>10.1016/j.amjcard.2021.07.029</ce:doi></ce:refers-to-document></ce:document-thread><ce:copyright type="unknown" year="2021"/></ja:item-info><ja:head><ce:dochead id="doc001"><ce:textfn id="cetextfn0001a">Data Article</ce:textfn></ce:dochead><ce:title id="tte0002">The characteristics of mitral regurgitation: Data from patients admitted following acute myocardial infarction</ce:title><ce:author-group id="aut0001"><ce:author id="au0001" author-id="S2352340921007332-5dc945dbd46846e89c75a99ebcc88d60"><ce:given-name>Harish</ce:given-name><ce:surname>Sharma</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0001" type="email" xlink:href="mailto:harish.sharma@nhs.net">harish.sharma@nhs.net</ce:e-address><ce:e-address id="ea4" type="social-media" xlink:href="https://twitter.com/Harish_Sharma__">@Harish_Sharma__</ce:e-address></ce:author><ce:author id="au0002" author-id="S2352340921007332-a0752cd72e50bf5d47bca0268f86ace5" orcid="0000-0003-2352-8353"><ce:given-name>Ashwin</ce:given-name><ce:surname>Radhakrishnan</ce:surname><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0003" author-id="S2352340921007332-21239ea3db7169df23416d1699a4814c"><ce:given-name>Peter</ce:given-name><ce:surname>Nightingale</ce:surname><ce:cross-ref refid="aff0003"><ce:sup loc="post">c</ce:sup></ce:cross-ref></ce:author><ce:author id="au0004" author-id="S2352340921007332-004a15214405bce9feb9074061b9cb17" orcid="0000-0003-2173-1251"><ce:given-name>Samuel</ce:given-name><ce:surname>Brown</ce:surname><ce:cross-ref refid="aff0004"><ce:sup loc="post">d</ce:sup></ce:cross-ref></ce:author><ce:author id="au0005" author-id="S2352340921007332-2ebfafcc647fea47d342239549105319"><ce:given-name>John</ce:given-name><ce:surname>May</ce:surname><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0006" author-id="S2352340921007332-547741add951f5d30bc45ecbb3d2e95c"><ce:given-name>Kieran</ce:given-name><ce:surname>O'Connor</ce:surname><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0007" author-id="S2352340921007332-3b19f571bde95c465e1f81666fd87b6c"><ce:given-name>Iqra</ce:given-name><ce:surname>Shakeel</ce:surname><ce:cross-ref refid="aff0004"><ce:sup loc="post">d</ce:sup></ce:cross-ref></ce:author><ce:author id="au0008" author-id="S2352340921007332-0a96c1bbd698f4c647de40cfcbb7fcc1" orcid="0000-0001-5012-3648"><ce:given-name>Nawal</ce:given-name><ce:surname>Zia</ce:surname><ce:cross-ref refid="aff0004"><ce:sup loc="post">d</ce:sup></ce:cross-ref></ce:author><ce:author id="au0009" author-id="S2352340921007332-3944dd5a74ab8558da7d3b4e2279c892"><ce:given-name>Sagar N.</ce:given-name><ce:surname>Doshi</ce:surname><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0010" author-id="S2352340921007332-5dd8f7143eacaad7c9e93a62cff09314" orcid="0000-0002-5881-5806"><ce:given-name>Jonathan N.</ce:given-name><ce:surname>Townend</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0011" author-id="S2352340921007332-e2c12be5a5043c662495a17cab2317be" orcid="0000-0001-5927-0230"><ce:given-name>Saul G.</ce:given-name><ce:surname>Myerson</ce:surname><ce:cross-ref refid="aff0005"><ce:sup loc="post">e</ce:sup></ce:cross-ref></ce:author><ce:author id="au0012" author-id="S2352340921007332-1119f39c0996439072a89f8b5cbd7c39"><ce:given-name>Paulus</ce:given-name><ce:surname>Kirchhof</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0006"><ce:sup loc="post">f</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0007"><ce:sup loc="post">g</ce:sup></ce:cross-ref></ce:author><ce:author id="au0013" author-id="S2352340921007332-673fefe606bce77712c1cb96670e0d05"><ce:given-name>Peter F.</ce:given-name><ce:surname>Ludman</ce:surname><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0014" author-id="S2352340921007332-4b50e1ce8575f72f32257076a83a839e"><ce:given-name>M.</ce:given-name><ce:surname>Adnan Nadir</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0015" author-id="S2352340921007332-ce770006f53d807cf3f9c42ef97bc5df" orcid="0000-0001-5687-2535"><ce:given-name>Richard P.</ce:given-name><ce:surname>Steeds</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="aff0001" affiliation-id="S2352340921007332-dc434fb5e53094b60b4e83d1f43799aa"><ce:label>a</ce:label><ce:textfn id="cetextfn0001">Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK</ce:textfn><sa:affiliation><sa:organization>Institute of Cardiovascular Sciences</sa:organization><sa:organization>University of Birmingham</sa:organization><sa:city>Birmingham</sa:city><sa:country>UK</sa:country></sa:affiliation><ce:source-text id="staff0001">aInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham, United KingdomK</ce:source-text></ce:affiliation><ce:affiliation id="aff0002" affiliation-id="S2352340921007332-be9a047955ea4b9f3efc7903a70b6460"><ce:label>b</ce:label><ce:textfn id="cetextfn0002">Department of Cardiology, University Hospitals Birmingham, Birmingham, UK</ce:textfn><sa:affiliation><sa:organization>Department of Cardiology</sa:organization><sa:organization>University Hospitals Birmingham</sa:organization><sa:city>Birmingham</sa:city><sa:country>UK</sa:country></sa:affiliation><ce:source-text id="staff0002">bDepartment of Cardiology, University Hospitals Birmingham, Birmingham, United KingdomK</ce:source-text></ce:affiliation><ce:affiliation id="aff0003" affiliation-id="S2352340921007332-79c2d8019678670a3746e5a2d255bfba"><ce:label>c</ce:label><ce:textfn id="cetextfn0003">Institute of Translational Medicine, University Hospitals Birmingham, Birmingham, UK</ce:textfn><sa:affiliation><sa:organization>Institute of Translational Medicine</sa:organization><sa:organization>University Hospitals Birmingham</sa:organization><sa:city>Birmingham</sa:city><sa:country>UK</sa:country></sa:affiliation><ce:source-text id="staff0003">cInstitute of Translational Medicine, University Hospitals Birmingham, Birmingham, United KingdomK</ce:source-text></ce:affiliation><ce:affiliation id="aff0004" affiliation-id="S2352340921007332-6b4a2e109e2aaaf0810ff6374b5b7feb"><ce:label>d</ce:label><ce:textfn id="cetextfn0004">Medical School, College of Medical and Dental Sciences, University of Birmingham, UK</ce:textfn><sa:affiliation><sa:organization>Medical School</sa:organization><sa:organization>College of Medical and Dental Sciences</sa:organization><sa:organization>University of Birmingham</sa:organization><sa:country>UK</sa:country></sa:affiliation><ce:source-text id="staff0004">dMedical School, College of Medical and Dental Sciences, University of Birmingham, United KingdomK</ce:source-text></ce:affiliation><ce:affiliation id="aff0005" affiliation-id="S2352340921007332-0df5b832759a184118abd53e7dac8632"><ce:label>e</ce:label><ce:textfn id="cetextfn0005">Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK</ce:textfn><sa:affiliation><sa:organization>Division of Cardiovascular Medicine</sa:organization><sa:organization>Radcliffe Department of Medicine</sa:organization><sa:organization>University of Oxford</sa:organization><sa:city>Oxford</sa:city><sa:country>UK</sa:country></sa:affiliation><ce:source-text id="staff0005">eDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United KingdomK</ce:source-text></ce:affiliation><ce:affiliation id="aff0006" affiliation-id="S2352340921007332-ccf84d2da5d8a53e42780275d09603cd"><ce:label>f</ce:label><ce:textfn id="cetextfn0006">Department of Cardiology, University Heart and Vascular Center UKE Hamburg, Germany</ce:textfn><sa:affiliation><sa:organization>Department of Cardiology</sa:organization><sa:organization>University Heart and Vascular Center UKE Hamburg</sa:organization><sa:country>Germany</sa:country></sa:affiliation><ce:source-text id="staff0006">fDepartment of Cardiology, University Heart and Vascular Center UKE Hamburg, Germany</ce:source-text></ce:affiliation><ce:affiliation id="aff0007" affiliation-id="S2352340921007332-665db2bb2f86afe874dc75fe14e67c6e"><ce:label>g</ce:label><ce:textfn id="cetextfn0007">German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/L&#252;beck, Germany</ce:textfn><sa:affiliation><sa:organization>German Center for Cardiovascular Research (DZHK)</sa:organization><sa:organization>Partner Site Hamburg/Kiel/L&#252;beck</sa:organization><sa:country>Germany</sa:country></sa:affiliation><ce:source-text id="staff0007">gGerman Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/L&#252;beck, Germany</ce:source-text></ce:affiliation><ce:correspondence id="cor0001"><ce:label>&#x204e;</ce:label><ce:text id="cetext0001">Corresponding author.</ce:text></ce:correspondence></ce:author-group><ce:date-received day="5" month="8" year="2021"/><ce:date-revised day="27" month="9" year="2021"/><ce:date-accepted day="1" month="10" year="2021"/><ce:abstract id="abs0001" view="all" class="author"><ce:section-title id="cesectitle0001">Abstract</ce:section-title><ce:abstract-sec id="abss0001" view="all"><ce:simple-para id="spara006" view="all">Data were collected on patients admitted to the Queen Elizabeth Hospital Birmingham with type-1 myocardial infarction during 2016 and 2017 inclusively, who were treated by percutaneous intervention and had pre-discharge transthoracic echocardiography. The data were obtained from prospectively maintained hospital databases and records. Echocardiography was performed and reported contemporaneously by accredited echocardiographers. The purpose was to understand the prevalence and characteristics of mitral regurgitation (MR) after acute MI, including patients with ST-elevation (STEMI) and non-ST elevation MI (NSTEMI). MR was observed in 294/1000 patients with the following relative severities: mild&#160;=&#160;76%, moderate&#160;=&#160;21%, severe&#160;=&#160;3% [1]. MR was graded by multiparametric quantification including proximal isolvelocity surface area (PISA), vena contracta (VC), effective regurgitant orifice area (EROA) and regurgitant volume (RVol). Amongst all patients with MR (n=294), PISA was performed in 89/294 (30%), VC 75/294 (26%), EROA in 53/294 (18%) and RVol in 26/294 (9%). Amongst patients with moderate or severe MR (n=70), PISA was performed in 57/70 (81%), VC in 55/70 (79%), EROA in 46/70 (66%) and RVol in 25/70 (36%). Characteristics of MR following acute MI were also assessed including frequency of reported leaflet thickness (259/294&#160;=&#160;88%) and mitral annular calcification (102/294&#160;=&#160;35%). Furthermore, the effect of MI on pre-existing MR was investigated and patients with pre-existing MR who continue to have MR after acute MI were found to have progression of MR by one grade in approximately 25% of cases. Finally, using Cox proportional hazards univariate analysis, significant factors associated with mortality in patients with MR post-MI include age (HR 1.065; 95% CI 1.035-1.096; p&lt;0.001), creatinine clearance, (HR 0.981; 95% CI 0.971-0.991; p&lt;0.001), left ventricular ejection fraction (LVEF) (HR 0.966; 95% CI 0.948-0.984; p&lt;0.001), indexed left ventricular end-diastolic volume (LVEDVi) (HR 1.016; 95% CI 1.003-1.029; p=0.018), indexed left ventricular end-systolic volume (LVESVi) (HR 1.021; 95% CI 1.008-1.034; p=0.001), indexed left atrial volume (HR 1.026; 95% CI 1.012-1.039; p&lt;0.001), and those with intermediate likelihood of pulmonary hypertension (pHTN) (HR 2.223; 95% CI 1.126-4.390; p=0.021); or high likelihood of pHTN (HR 5.626; 95% CI 2.189-14.461; p&lt;0.001). Age and LVEF were found to be independent predictors of mortality on multivariate analysis [1].</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id="keys0001" view="all" class="keyword"><ce:section-title id="cesectitle0002">Keywords</ce:section-title><ce:keyword id="key0001"><ce:text id="cetext0002">Mitral regurgitation</ce:text></ce:keyword><ce:keyword id="key0002"><ce:text id="cetext0003">Secondary MR</ce:text></ce:keyword><ce:keyword id="key0003"><ce:text id="cetext0004">Myocardial infarction</ce:text></ce:keyword><ce:keyword id="key0004"><ce:text id="cetext0005">Valvular disease</ce:text></ce:keyword></ce:keywords></ja:head></ja:article></doc:document>
